Ondine Biomedical Inc. (LON:OBI – Get Free Report) was up 11.8% during mid-day trading on Friday . The company traded as high as GBX 8.50 ($0.11) and last traded at GBX 8.39 ($0.11). Approximately 240,443 shares traded hands during trading, a decline of 20% from the average daily volume of 299,669 shares. The stock had previously closed at GBX 7.50 ($0.10).
Ondine Biomedical Stock Up 10.0 %
The company has a market capitalization of £22.88 million, a price-to-earnings ratio of -137.50 and a beta of -0.01. The business’s 50-day moving average is GBX 7.04 and its 200-day moving average is GBX 8.56. The company has a quick ratio of 8.26, a current ratio of 2.34 and a debt-to-equity ratio of 24.39.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Further Reading
- Five stocks we like better than Ondine Biomedical
- Russell 2000 Index, How Investors Use it For Profitable Trading
- McDonald’s Stock: Balancing Value and Innovation
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 6/17 – 6/21
- Stock Dividend Cuts Happen Are You Ready?
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
